109 related articles for article (PubMed ID: 30706477)
1. Large-Scale Screening of Natural Products Transactivating Peroxisome Proliferator-Activated Receptor α Identifies 9S-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid and Cymarin as Potential Compounds Capable of Increasing Apolipoprotein A-I Transcription in Human Liver Cells.
van der Krieken SE; Popeijus HE; Bendik I; Böhlendorf B; Konings MCJM; Tayyeb J; Mensink RP; Plat J
Lipids; 2018 Nov; 53(11-12):1021-1030. PubMed ID: 30706477
[TBL] [Abstract][Full Text] [Related]
2. Short-Chain Fatty Acids (Except Hexanoic Acid) Lower NF-kB Transactivation, Which Rescues Inflammation-Induced Decreased Apolipoprotein A-I Transcription in HepG2 Cells.
Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mokhtar FBA; Plat J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708494
[TBL] [Abstract][Full Text] [Related]
3. Link Between ER-Stress, PPAR-Alpha Activation, and BET Inhibition in Relation to Apolipoprotein A-I Transcription in HepG2 Cells.
van der Krieken SE; Popeijus HE; Mensink RP; Plat J
J Cell Biochem; 2017 Aug; 118(8):2161-2167. PubMed ID: 28012209
[TBL] [Abstract][Full Text] [Related]
4. The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.
Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
J Cell Biochem; 2019 Oct; 120(10):17219-17227. PubMed ID: 31106471
[TBL] [Abstract][Full Text] [Related]
5. Amoxicillin Modulates ApoA-I Transcription and Secretion, Predominantly via PPARα Transactivation Inhibition.
Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783518
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid chain length and saturation influences PPARα transcriptional activation and repression in HepG2 cells.
Popeijus HE; van Otterdijk SD; van der Krieken SE; Konings M; Serbonij K; Plat J; Mensink RP
Mol Nutr Food Res; 2014 Dec; 58(12):2342-9. PubMed ID: 25255786
[TBL] [Abstract][Full Text] [Related]
7. Search for Natural Compounds That Increase Apolipoprotein A-I Transcription in HepG2 Cells: Specific Attention for BRD4 Inhibitors.
van der Krieken SE; van-der Pijl PC; Lin Y; Popeijus HE; Mensink RP; Plat J
Lipids; 2019 Nov; 54(11-12):687-695. PubMed ID: 31814132
[TBL] [Abstract][Full Text] [Related]
8. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
[TBL] [Abstract][Full Text] [Related]
9. Effects of Individual Amino Acids on PPARα Transactivation, mTORC1 Activation, ApoA-I Transcription and pro-ApoA-I Secretion.
Tayyeb JZ; Popeijus HE; van de Sanden J; Zwaan W; Mensink RP; Plat J
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682748
[TBL] [Abstract][Full Text] [Related]
10. Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.
Siripurkpong P; Na-Bangchang K
J Nutr Biochem; 2009 Apr; 20(4):261-8. PubMed ID: 18602814
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
Shi ST; Li YF; Guo YQ; Wang ZH
J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells.
Zhang LH; Kamanna VS; Ganji SH; Xiong XM; Kashyap ML
J Lipid Res; 2010 Aug; 51(8):2211-22. PubMed ID: 20371549
[TBL] [Abstract][Full Text] [Related]
13. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
[TBL] [Abstract][Full Text] [Related]
14. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.
Pandey NR; Renwick J; Misquith A; Sokoll K; Sparks DL
Biochemistry; 2008 Feb; 47(6):1579-87. PubMed ID: 18189424
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
[TBL] [Abstract][Full Text] [Related]
16. Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.
Nagasawa M; Hara T; Kashino A; Akasaka Y; Ide T; Murakami K
Biochem Pharmacol; 2009 Sep; 78(5):523-30. PubMed ID: 19433068
[TBL] [Abstract][Full Text] [Related]
17. PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.
Shavva VS; Mogilenko DA; Bogomolova AM; Nikitin AA; Dizhe EB; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
J Cell Biochem; 2016 Sep; 117(9):2010-22. PubMed ID: 26813964
[TBL] [Abstract][Full Text] [Related]
18. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
